Jonathan Mercer, MD
Urology · Kalispell, MTNPI 1992746192
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Coloplast at 38.4% of the total. Reporting peaked in 2020 at $757 and has fallen 79.1% since, to $158 in 2025. That places this record below the midpoint for urology clinicians in MT, where the typical reported total is $1,996.
Across 28 payments — averaging $63.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$683
- Astellas Pharma US Inc$233
- EMD Serono, Inc.$175
- Comsort, Inc$100
- Healthtronics Stone Solutions, LLC$87
- Axonics, Inc.$79
- plus $423 from 12 others
What the payments were for
- Consulting fees$1006%
- Travel & lodging$68338%
- Food & beverage$84347%
- Education$1539%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 1 | $683 |
| Astellas Pharma US Inc | 4 | $233 |
| EMD Serono, Inc. | 2 | $175 |
| Comsort, Inc | 1 | $100 |
| Healthtronics Stone Solutions, LLC | 1 | $87 |
| Axonics, Inc. | 2 | $79 |
| Laborie Medical Technologies Corp. | 1 | $65 |
| Myovant Sciences Inc. | 4 | $63 |
| AbbVie | 2 | $57 |
| Antares Pharma, Inc. | 1 | $44 |
| Intuitive Surgical | 1 | $44 |
| Calyxo, Inc. | 1 | $43 |
| Myriad Genetic Laboratories, Inc. | 2 | $32 |
| Endo USA, Inc. | 1 | $27 |
| Merck | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Pfizer | 1 | $13 |
| Travere Therapeutics, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,779 in reported general payments places this provider in the 45th percentile of 45 urology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 55 | $50,666 |
| GemtesaVibegron | 22 | $17,214 |
| PremarinEstrogens, Conjugated | 13 | $5,792 |
| Tamsulosin Hcl | 340 | $5,445 |
| Potassium Citrate ErPotassium Citrate | 21 | $2,997 |
| Estradiol | 21 | $1,404 |
| Silodosin | 21 | $894 |
| Finasteride | 57 | $817 |
| Oxybutynin Chloride | 106 | $800 |
| Testosterone Cypionate | 14 | $730 |
| CefuroximeCefuroxime Axetil | 30 | $476 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 20 | $437 |
| Ciprofloxacin Hcl | 51 | $388 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 59 | $284 |
| Doxycycline Hyclate | 14 | $240 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $233 | $50,66655 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $15 | $17,21422 claims |
| PfizerPremarin | $13 | $5,79213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 45 urology providers in Montana.
Other urology in Kalispell
- Amy McKerrowKalispell$9K
- Sarabeth MartinKalispell$4K
- John AndenoroKalispell$3K
- Geraldine SheuKalispell$2K
- Vassilis SiomosKalispell$2K
- Gregory AdamsKalispell$669
- Michael BersonKalispell$95
- Craig HinmanKalispell$29
- Christopher FukudaGreat Falls$19K
- Garrick SimmonsMissoula$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.